Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
Stefan M. Willems(The Netherlands Cancer Institute), Judith V.M.G. Bovée(Leiden University Medical Center)
Cited by 28
Related Papers
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
|British Journal of Cancer|2018|61
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
|Oncogenesis|2018|57
<scp>HPV</scp>‐positive oropharyngeal squamous cell carcinoma is associated with <i><scp>TIMP</scp>3</i> and <i><scp>CADM</scp>1</i> promoter hypermethylation
|Cancer Medicine|2014|53
Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
|BMC Cancer|2012|43
Targeting survivin as a potential new treatment for chondrosarcoma of bone
|Oncogenesis|2016|34